Fierce Pharma

DECEMBER 21, 2023

As Vertex Pharmaceuticals and CRISPR Therapeutics lay the groundwork for the launch of their CRISPR-based gene-editing therapy Casgevy, one doctor who treats sickle cell disease patients is already | As Vertex Pharmaceuticals and CRISPR Therapeutics lay the groundwork for the launch of their world-first CRISPR-based gene therapy Casgevy, one doctor who treats sickle cell disease patients is already seeing strong demand.

Doctors 323

Doctors Pharmaceutical Patients 323

MedCity News

DECEMBER 21, 2023

Guidehealth, a nascent value-based care enablement startup, acquired Arcadia’s value-based care service division. Acquiring this business unit allows Guidehealth to provide health systems with a platform that helps them succeed in value-based care arrangements while still maintaining their patient volume levels.

Patients 122

Patients 122

Fierce Pharma

DECEMBER 21, 2023

Big Pharma companies have often talked about the major opportunities that await in China. | Big Pharma companies have often talked about the major opportunities that await in China. But as price cuts play out and internal priorities shift, multinational companies are reworking their business models in the country.

Pharma 317

Pharma 317

MedCity News

DECEMBER 21, 2023

Of those with employer-sponsored insurance, 31% of lower-income adults reported having trouble paying their medical bills, versus 13% of higher-income adults, according to a new report from KFF.

Insurance 119

Insurance Medical 119

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 21, 2023

Two years ago, with a favorable ruling and a slap-on-the | A favorable ruling two years ago had Servier hoping that its decades-long litigation surrounding weight-loss pill Mediator was finally over. But an appeal from prosecutors now leaves the company facing a hefty penalty.

278

278

MedCity News

DECEMBER 21, 2023

Right-now value could come from extractive AI, a tool that gives organizations the power to put even handwritten text sent via images or PDF by digital fax into a structured data play.

Healthcare 116

Healthcare Healthcare 116

PharmaTimes

DECEMBER 21, 2023

The condition affects around 270,935 people in England and 16,090 people in Wales - News - PharmaTimes

115

115

Fierce Pharma

DECEMBER 21, 2023

Ionis Pharmaceuticals and AstraZeneca are wrapping up the year with a much-anticipated present from the FDA: an approval for the companies’ transthyretin amyloidosis (ATTR) drug Wainua. | The approval in hereditary transthyretin-mediated amyloid polyneuropathy, which affects around 40,000 to 50,000 patients globally, sets the stage for a potential label expansion down the line to treat the broader transthyretin amyloid cardiomyopathy patient population.

FDA 278

FDA Pharmaceutical Patients 278

MedCity News

DECEMBER 21, 2023

Javier Gonzalez, Chief Growth and Commercial Officer at Abarca, about why payers are increasingly looking for alternatives to the traditional PBM model.

Management 114

Management 114

Fierce Pharma

DECEMBER 21, 2023

Following the U.S. | Following the U.S. Federal Trade Commission's recent crackdown on "improper" patents in the FDA's Orange Book, GSK, Amneal and Kaleo have made the requested changes.

FDA 195

FDA 195

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmaTimes

DECEMBER 21, 2023

Bowel cancer is currently the third most common type of cancer in England - News - PharmaTimes

113

113

pharmaphorum

DECEMBER 21, 2023

NICE backs NHS use of digital COPD rehab programmes, myCOPD and SPACE for COPD, as an alternative to face-to-face consultations

Consulting 111

Consulting 111

MedCity News

DECEMBER 21, 2023

Knownwell’s $20 million Series A funding round was led by A16Z and included participation from Flare Capital Partners. The company also launched an adolescent metabolic health program.

111

111

pharmaphorum

DECEMBER 21, 2023

Sanofi ends development of CEACAM5-targeting ADC tusamitamab ravtansine after it fails a phase 3 trial in non-small cell lung cancer (NSCLC)

111

111

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

European Pharmaceutical Review

DECEMBER 21, 2023

A study carried out by scientists from the University of Texas at Arlington (UTA) has found that using carbonated water in chromatography makes this relatively common chemical technique more environmentally benign. The research, led by Daniel W. Armstrong, the Welch Distinguished Professor of Chemistry and Biochemistry at UTA, was published in Green Chemistry.

Safety 105

Safety Pharmaceutical 105

pharmaphorum

DECEMBER 21, 2023

Lilly partners with Fauna Bio in $494m deal to see if a hibernating squirrel's genomics could unlock new obesity drug targets.

111

111

European Pharmaceutical Review

DECEMBER 21, 2023

Piramal Pharma Solutions has officially opened new facilities at its antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland. This expansion enhances the site’s capacity by 70-80 percent and will enable scale-up of commercial ADC manufacturing batches. “The global ADC market is growing strongly and so is the pipeline at Grangemouth, necessitating additional capacity to meet customer demand,” said Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions.

Manufacturing 98

Manufacturing Government Pharma Marketing 98

pharmaphorum

DECEMBER 21, 2023

An organisation representing the interests of patients with prostate cancer has published a manifesto ahead of the EU elections next year, calling for more screening for the disease in EU member states.

Patients 110

Patients 110

Advertisement

Pharmaceutical Technology

DECEMBER 21, 2023

Genevoyager has announced the opening of contract development and manufacturing organisation facility to manufacture gene therapy products.

Manufacturing 97

Manufacturing 97

pharmaphorum

DECEMBER 21, 2023

Indivior has secured a $111 million BARDA supply contract in the US for its Opvee intranasal therapy for treating opioid overdose

105

105

PharmaTimes

DECEMBER 21, 2023

The National Institute for Health and Care Excellence (NICE) has published final guidance announcing a five-year roll-out of a wearable technology for patients living with type 1 diabetes. The new hybrid closed loop systems have proven to be more effective in maintaining healthy blood glucose levels than standard care. The new guidance followed a review of a clinical trial and real-world evidence by the University of Warwick and Warwick Medical School, funded by the National Institute for Health

Medical 82

Medical Training Patients 82

pharmaphorum

DECEMBER 21, 2023

Servier has been found guilty of fraud and deception over weight loss therapy Mediator by French appeals court, and is fined €431 million

102

102

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTimes

DECEMBER 21, 2023

The NHS has announced the expansion of its home-testing kits for bowel cancer in an effort to detect signs of the disease and diagnose it earlier. The expansion of the NHS Bowel Cancer Screening Programme aligns with the health service’s aim of detecting cancers at an earlier stage when they are easier to treat. Currently the third most common type of cancer in England and responsible for almost 43,000 new cases in the UK every year, bowel cancer starts in the large bowel (colon) and the back pa

73

73

pharmaphorum

DECEMBER 21, 2023

FDA issues a second complete response letter to MSD's gefapixant for chronic cough, giving GSK a chance to catch up with camlipixant

FDA 98

FDA 98

Pharmacy Times

DECEMBER 21, 2023

Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.

Management 61

Management Medical Patients 61

PharmaVoice

DECEMBER 21, 2023

Closer scrutiny of pharma deals has made the M&A landscape trickier as a new approach seeks to expand the competitive arena.

Competition 59

Competition Pharma 59

Advertisement

Distribution

Pharmacy Times

DECEMBER 21, 2023

Overtime, children can outgrow food allergies, like milk and eggs—however, children with private insurance are more likely to outgrow allergies than those with public insurance.

Insurance 58

Insurance Food 58

Pharmaceutical Technology

DECEMBER 21, 2023

Discover a groundbreaking method to treat cancer using a combination of mitochondrial and Bcl-2 inhibitors. Learn more about this patent's innovative approach.

Pharma 52

Pharma 52

Pharmacy Times

DECEMBER 21, 2023

Comprehensive medication reviews and drug interaction assessments are examples of clinical interventions

Medical 58

Medical Management 58

Pharmaceutical Technology

DECEMBER 21, 2023

Diakine-DK210 (EGFR) is under clinical development by Deka Biosciences and currently in Phase I for Pancreatic Cancer.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales